Global Chronic Kidney Disease Medication Market Segmentation, By Drug Class (Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Renin-Angiotensin System Inhibitors, Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors, Diuretics, and Other Medications), Treatment Stage (Early-Stage CKD, Moderate-Stage CKD, and End-Stage CKD), End User (Hospitals, Clinics, Home Care Settings, and Dialysis Centers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others) – Industry Trends and Forecast to 2032
read more..